tiprankstipranks
OSE Immunotherapeutics SA (DE:6OP)
FRANKFURT:6OP
Holding DE:6OP?
Track your performance easily

OSE Immunotherapeutics SA (6OP) Financial Statements

1 Followers

OSE Immunotherapeutics SA Financial Overview

OSE Immunotherapeutics SA's market cap is currently ―. The company's EPS TTM is €2.088; its P/E ratio is 4.12; OSE Immunotherapeutics SA is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 31.19M€ 33.58M€ 27.26M€ 29.37M€ 22.92M
Total Assets€ 102.27M€ 101.88M€ 98.21M€ 96.97M€ 90.75M
Total Debt€ 35.77M€ 37.13M€ 23.93M€ 19.51M€ 19.83M
Net Debt€ 4.58M€ 3.56M€ -3.34M€ -9.85M€ -3.09M
Total Liabilities€ 55.47M€ 53.99M€ 45.91M€ 35.61M€ 34.32M
Stockholders Equity€ 46.80M€ 47.89M€ 52.31M€ 61.36M€ 56.42M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

OSE Immunotherapeutics SA Earnings and Revenue History

OSE Immunotherapeutics SA Debt to Assets

OSE Immunotherapeutics SA Cash Flow

OSE Immunotherapeutics SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis